SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here
CVAS 0.0004000.0%Oct 7 9:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (85)5/16/2002 10:34:35 PM
From: Miljenko Zuanic  Read Replies (1) of 126
 
Rising cost for R&D, rising cost for clinical practice, rising salary <grrr>, rising bonus <grrr exp n., rising failure rate (ops, this do not belong here), rising sun on west (maybe east, one day),...and you get your burn under control. <g>

Currently they are doing pharmacokinetic for i.v. rNAPc2 (PIb before going with PII) and toxicology + additional efficacy model for lead proteosome inhibitor. I already deducted +$40M from cash, so they are now at ~ZERO technology value. Nice perspective? <g>

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext